These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 23748287

  • 1. Recent insights into the pathogenesis of nephrotic syndrome.
    Certikova-Chabova V, Tesar V.
    Minerva Med; 2013 Jun; 104(3):333-47. PubMed ID: 23748287
    [Abstract] [Full Text] [Related]

  • 2. [Minimal change nephrotic syndrome : new insights into disease pathogenesis].
    Audard V, Lang P, Sahali D.
    Med Sci (Paris); 2008 Oct; 24(10):853-8. PubMed ID: 18950582
    [Abstract] [Full Text] [Related]

  • 3. [Nephrotic syndrome].
    Sugiyama H, Makino H.
    Nihon Rinsho; 2005 May; 63 Suppl 5():521-5. PubMed ID: 15954403
    [No Abstract] [Full Text] [Related]

  • 4. Pediatric nephrotic syndrome: from the simple to the complex.
    Lane JC, Kaskel FJ.
    Semin Nephrol; 2009 Jul; 29(4):389-98. PubMed ID: 19615560
    [Abstract] [Full Text] [Related]

  • 5. Minimal change disease: a CD80 podocytopathy?
    Ishimoto T, Shimada M, Araya CE, Huskey J, Garin EH, Johnson RJ.
    Semin Nephrol; 2011 Jul; 31(4):320-5. PubMed ID: 21839364
    [Abstract] [Full Text] [Related]

  • 6. [Pathogenesis of immune glomerulonephritis].
    Rougier JP, Ronco P.
    Rev Prat; 2003 Nov 30; 53(18):1998-2004. PubMed ID: 15008213
    [Abstract] [Full Text] [Related]

  • 7. Vascular hyperpermeability in nephrotic edema.
    Rostoker G, Behar A, Lagrue G.
    Nephron; 2000 Jul 30; 85(3):194-200. PubMed ID: 10867533
    [Abstract] [Full Text] [Related]

  • 8. [Primary and secondary glomerular diseases].
    Birck R, Banas B.
    Dtsch Med Wochenschr; 2011 Apr 30; 136(14):703-5. PubMed ID: 21448831
    [No Abstract] [Full Text] [Related]

  • 9. [Evaluation of the podocytes in urine in the nephrotic syndrome in childhood].
    Spadło A, Wyka K, Kowalewska-Pietrzak M, Bodalski J.
    Pol Merkur Lekarski; 2007 Apr 30; 22(130):254-7. PubMed ID: 17684921
    [Abstract] [Full Text] [Related]

  • 10. Effects of cyclosporin A on glomerular barrier function in the nephrotic syndrome.
    Zietse R, Wenting GJ, Kramer P, Schalekamp MA, Weimar W.
    Clin Sci (Lond); 1992 Jun 30; 82(6):641-50. PubMed ID: 1320544
    [Abstract] [Full Text] [Related]

  • 11. Glomerular filtration barrier in pediatric idiopathic nephrotic syndrome.
    Sharma A, Gupta R, Bagga A, Dinda AK.
    Saudi J Kidney Dis Transpl; 2013 Mar 30; 24(2):286-91. PubMed ID: 23538351
    [Abstract] [Full Text] [Related]

  • 12. Global glomerulosclerosis with nephrotic syndrome; the clinical importance of age adjustment.
    Hommos MS, Zeng C, Liu Z, Troost JP, Rosenberg AZ, Palmer M, Kremers WK, Cornell LD, Fervenza FC, Barisoni L, Rule AD.
    Kidney Int; 2018 May 30; 93(5):1175-1182. PubMed ID: 29273332
    [Abstract] [Full Text] [Related]

  • 13. [Minimal change glomerulonephritis, diffuse mesangioproliferative glomerulonephritis and focal and segmental glomerular sclerosis and hyalinosis].
    Belovezhdov N.
    Vutr Boles; 1984 May 30; 23(4):42-6. PubMed ID: 6506660
    [Abstract] [Full Text] [Related]

  • 14. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome.
    Wagrowska-Danilewicz M, Stasikowska O, Danilewicz M.
    Pol J Pathol; 2006 May 30; 57(1):17-21. PubMed ID: 16739878
    [Abstract] [Full Text] [Related]

  • 15. C1q nephropathy: features at presentation and outcome.
    Lau KK, Gaber LW, Delos Santos NM, Wyatt RJ.
    Pediatr Nephrol; 2005 Jun 30; 20(6):744-9. PubMed ID: 15827744
    [Abstract] [Full Text] [Related]

  • 16. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. I. The role of proteinuria, hypoproteinemia, and renin-angiotensin-aldosterone system on sodium retention.
    Pedraza-Chaverrí J, Cruz C, Ibarra-Rubio ME, Chávez MT, Calleja C, Tapia E, del Carmen Uribe M, Romero L, Peña JC.
    Rev Invest Clin; 1990 Jun 30; 42(1):29-38. PubMed ID: 2236972
    [Abstract] [Full Text] [Related]

  • 17. Pharmacologic management of adult idiopathic nephrotic syndrome.
    Alaniz C, Brosius FC, Palmieri J.
    Clin Pharm; 1993 Jun 30; 12(6):429-39. PubMed ID: 8403814
    [Abstract] [Full Text] [Related]

  • 18. Pathogenesis of "idiopathic" nephrotic syndrome.
    Ritz E.
    N Engl J Med; 1994 Jan 06; 330(1):61-2. PubMed ID: 8259147
    [No Abstract] [Full Text] [Related]

  • 19. [Structure and function of the glomerular filtration barrier].
    Musiał K, Zwolińska D.
    Pol Merkur Lekarski; 2005 Mar 06; 18(105):317-20. PubMed ID: 15997642
    [Abstract] [Full Text] [Related]

  • 20. [Up to date of pathophysiology mechanism of idiopathic nephrotic syndromes: Minimal change disease and focal and segmental glomerulosclerosis].
    Dumas De La Roque C, Combe C, Rigothier C.
    Nephrol Ther; 2018 Dec 06; 14(7):501-506. PubMed ID: 30150079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.